News Archives
August, 2008Lakewood Pathology Enter $1 Billion GI Testing Market, Renamed PLUS Diagnostics
August, 2008
PLUS Diagnostics Aims for $50M With Eye on HEMPATH
July 21, 2008
Lakewood Pathology Announces New Name
May 19, 2008
Lakewood Pathology Launches National Gastrointestinal Diagnostic Services
April 15, 2008
Lakewood Pathology Associates appoints Dave Pauluzzi President, COO
May 16, 2007
Lakewood Pathology Associates names Doug Berg Chief Executive Officer
July 18, 2006
LPA highlighted in July 2006 Urology Times Article by Neil Baum, MD
June 19, 2006
Philadelphia Business Journal: LPA gets $50 million infusion from Water Street Capital Partners
May 16, 2007
Lakewood Pathology names Doug Berg Chief Executive Officer
LAKEWOOD PATHOLOGY ASSOCIATES NAMES DOUG BERG CHIEF EXECUTIVE OFFICER.
May 16, 2007 - Company Appoints Industry Veteran Timothy Brodnik to Board
LAKEWOOD, N.J. - - Lakewood Pathology Associates, a leading U.S. anatomic pathology company providing a broad range of diagnostic testing and consultative services to doctors and clinicians, today announced that it has named Doug Berg its chief executive officer, effective immediately. Mr. Berg also has been appointed to Lakewood's board of directors. A 25-year industry veteran who previously served as the company's chief development officer, Mr. Berg replaces Dr. Raza Bokhari, who has decided to step down one year after the company transitioned to its new majority owner, Water Street Healthcare Partners, a private equity firm focused exclusively on the healthcare industry.
Prior to joining Lakewood, Mr. Berg held a variety of executive management positions at leading laboratory and healthcare organizations, including Quest Diagnostics, where as corporate vice president of sales and marketing, he helped the company nearly double its market capitalization by leading the development and execution of its growth strategy. He also served in senior leadership roles with Dade Behring, Baxter and American Hospital Supply Corporation.
"I am very excited to assume the CEO position for Lakewood. We have a huge opportunity in front of us to build upon our expertise and expand into new and dynamic areas of diagnostic services, such as molecular-based medical testing," said Mr. Berg. "In addition, Lakewood has an outstanding reputation for customer service, which I look forward to further extending into new markets across the U.S."
Timothy J. Brodnik Appointed Lead Director
Lakewood also announced today that Timothy J. Brodnik has been appointed lead director of the board. A long-time laboratory industry executive, Mr. Brodnik is the former president and CEO of American Medical Laboratories (AML), which was sold to Quest Diagnostics in a $500 million transaction in 2002.
"The addition of Tim to our board is another important element to Lakewood's success. He is one of the most talented and respected executives in the lab industry, and his experience in building and growing AML will be invaluable to us as we pursue new growth opportunities for Lakewood and help position it for long-term success," said Jim Connelly, a Lakewood board member and a partner with Water Street Healthcare Partners.
Mr. Brodnik added, "I am looking forward to leveraging my success with AML to assist Lakewood in achieving its growth strategy. I am a firm believer that a nimble, customer-focused laboratory will compete very favorably in a market comprised of much larger companies. I look forward to assisting Doug and the Lakewood management team in further developing and executing on their strategy."